VolitionRx Files 10-Q/A Amendment for Exhibit Inclusion
Ticker: VNRX · Form: 10-Q/A · Filed: Aug 15, 2025 · CIK: 93314
Sentiment: neutral
Topics: filing-amendment, exhibit-omission, regulatory-compliance
Related Tickers: VNRX
TL;DR
VNRX filed an amendment to its 10-Q to add missing exhibits. No new financial info.
AI Summary
VolitionRx Limited filed an Amendment No. 1 on Form 10-Q/A on August 15, 2025, to its quarterly report for the period ended June 30, 2025. This amendment was filed solely to include Exhibits 5.1 and 10.2, which were inadvertently omitted from the original filing on August 14, 2025.
Why It Matters
This filing indicates a procedural correction in the company's reporting, ensuring all required documentation is present for regulatory compliance.
Risk Assessment
Risk Level: low — The amendment is purely administrative, correcting an omission of exhibits without altering the financial or operational content of the original report.
Key Players & Entities
- VolitionRx Limited (company) — Filer of the 10-Q/A
- August 15, 2025 (date) — Filing date of the amendment
- June 30, 2025 (date) — End of the quarterly period reported
- August 14, 2025 (date) — Original filing date of the Form 10-Q
FAQ
What is the purpose of this Form 10-Q/A filing?
This filing is an Amendment No. 1 to the original Form 10-Q to include Exhibits 5.1 and 10.2, which were inadvertently omitted.
When was the original Form 10-Q filed?
The original Form 10-Q for the quarterly period ended June 30, 2025, was filed on August 14, 2025.
What specific exhibits were missing from the original filing?
Exhibits 5.1 and 10.2 were inadvertently omitted from the original Form 10-Q.
Does this amendment change the financial information reported for the quarter ended June 30, 2025?
No, the amendment states it is being filed solely to include the omitted exhibits and does not appear to alter the financial or operational content of the original report.
What is the filing date for this Amendment No. 1?
This Amendment No. 1 on Form 10-Q/A was filed on August 15, 2025.
Filing Stats: 1,472 words · 6 min read · ~5 pages · Grade level 9.3 · Accepted 2025-08-15 17:16:42
Key Financial Figures
- $0.001 — ich Registered Common Stock, par value $0.001 per share VNRX NYSE American, LLC
Filing Documents
- vnrx_10qa.htm (10-Q/A) — 90KB
- vnrx_51.htm (EX-5.1) — 9KB
- vnrx_102.htm (EX-10.2) — 18KB
- vnrx_313.htm (EX-31.3) — 4KB
- vnrx_314.htm (EX-31.4) — 4KB
- vnrx_ex51img1.jpg (GRAPHIC) — 3KB
- 0001477932-25-005992.txt ( ) — 287KB
- vnrx-20250630.xsd (EX-101.SCH) — 5KB
- vnrx-20250630_lab.xml (EX-101.LAB) — 19KB
- vnrx-20250630_cal.xml (EX-101.CAL) — 1KB
- vnrx-20250630_pre.xml (EX-101.PRE) — 12KB
- vnrx-20250630_def.xml (EX-101.DEF) — 2KB
- vnrx_10qa_htm.xml (XML) — 6KB
EXHIBITS
ITEM 6. EXHIBITS Incorporated by Reference Exhibit Number Exhibit Description Form File No. Exhibit Filing Date Filed Herewith 3.1 Second Amended and Restated Certificate of Incorporation, as amended and currently in effect. S-3 333-288508 3.1 7/3/25 3.2 Amended and Restated Bylaws, as amended and currently in effect. 10-Q 001-36833 3.2 5/13/24 4.1
Description of Capital Stock
Description of Capital Stock . S-3 333-288508 4.2 7/3/25 5.1 Legal Opinion of Stradling Yocca Carlson & Rauth LLP. X 10.1 Capital On Demand TM Sales Agreement, dated April 22, 2025, by and between VolitionRx Limited and JonesTrading Institutional Services LLC. 8-K 001-36833 1.1 4/22/25 10.2 Amendment No. 1 to Capital On Demand TM Sales Agreement, dated August 14, 2025, by and between VolitionRx Limited and JonesTrading Institutional Services LLC. X 10.3 Securities Purchase Agreement, dated May 15, 2025, as amended June 26, 2025, by and between the Company and Lind Global Asset Management XII LLC. S-3 333-288508 4.3 7/3/25 10.4 Form of Senior Secured Convertible Promissory Note, dated May 15, 2025, issued by the Company to Lind Global Asset Management XII LLC. 10-Q 001-36833 10.3 5/15/25 10.5 Form of Common Stock Purchase Warrant, dated May 15, 2025, issued by the Company to Lind Global Asset Management XII LLC. 10-Q 001-36833 10.4 5/15/25 10.6 Security Agreement, dated May 15, 2025, by and between the Company and Lind Global Asset Management XII LLC. 10-Q 001-36833 10.5 5/15/25 10.7 Guaranty, dated May 15, 2025, by and among Singapore Volition Pte. Limited, Volition Global Services SRL, Belgian Volition SRL, Volition Diagnostics UK Limited, Volition America, Inc. and Volition Veterinary Diagnostics Development LLC, and Lind Global Asset Management XII LLC. 10-Q 001-36833 10.6 5/15/25 10.8 Pledge Agreement, dated May 15, 2025, by and between the Company and Lind Global Asset Management XII LLC. 10-Q 001-36833 10.7 5/15/25 10.9 Guarantor Security Agreement, dated May 15, 2025, by and among Singapore Volition Pte. Limited, Volition Global Services SRL, Belgian Volition SRL, Volition Diagnostics UK Limited, Volition America, Inc. and Volition Veterinary Diagnostics Development LLC, and Lind Global Asset Management XII LLC. 10-Q 001-36833 10.8 5/15/25 10.10 Pledge Agreement, dated May 15, 20
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. VOLITIONRX LIMITED Dated: August 15, 2025 By: /s/ Cameron Reynolds Cameron Reynolds President and Chief Executive Officer (Authorized Signatory and Principal Executive Officer) Dated: August 15, 2025 By: /s/ Terig Hughes Terig Hughes Chief Financial Officer and Treasurer (Authorized Signatory and Principal Financial and Accounting Officer) 4